SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001171843-21-005046
Filing Date
2021-07-23
Accepted
2021-07-23 08:41:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_072321.htm 425 24038
2 EXHIBIT 99.1 exh_991.htm EX-99.1 23774
3 GRAPHIC logo.jpg GRAPHIC 9987
  Complete submission text file 0001171843-21-005046.txt   63306
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filed by) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Subject) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 425 | Act: 34 | File No.: 001-35776 | Film No.: 211109130
SIC: 2834 Pharmaceutical Preparations